Policy & Regulation
Takara Bio USA Launches Automated, Full-Length Single-Cell RNA-seq Solution for Enhanced Biomarker Discovery
19 October 2021 - - Japanese biotechnology company Takara Bio Inc's US-based Takara Bio USA, Inc subsidiary has launched the SMART-Seq Pro kit for the ICELL8 cx Single-Cell System, the company sa...
PerkinElmer, Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis
19 October 2021 - - US-based life science company PerkinElmer, Inc. (NYSE: PKI) and US-based Honeycomb Biotechnologies, Inc., have launched the first of its kind HIVE scRNAseq...
AnHeart Therapeutics Launches Study to Evaluate AXL inhibitor AB-329 in Metastatic Breast Cancer
19 October 2021 - - US-based biopharmaceutical company AnHeart Therapeutics has launched sponsored research to evaluate AB-329, an AXL inhibitor in metastatic breast cancer, the company said.
Nordic Nanovector forms cancer research collaboration with University of Pennsylvania
19 October 2021 - Biopharmaceutical company Nordic Nanovector ASA (Oslo:NANOV) said on Tuesday that it has entered into a research collaboration with the University of Pennsylvania to generate a CD37-...
SoftOx enrols first patient in wound treatment trial
19 October 2021 - Norwegian biotech company SoftOx Solutions AS (Euronext Growth Oslo:SOFTX) announced on Tuesday that the first patient has been recruited to SBE-01, the clinical study of its wound t...
COVID-19 Vaccine Developed by Valneva Using Dynavax's CpG 1018 Adjuvant Meets Both Co-Primary Endpoints in Phase 3 COV-COMPARE Trial
19 October 2021 - - French biotechnology company Valneva SE has reported positive topline results from the Phase 3 pivotal trial of VLA2001, their inactivated COVID-19 vaccine candidate using US-...